News

Gov. Jerry Brown is launching a statewide initiative with the University of California, to advance the field of precision medicine. The effort will involve collaborating with other academic and industry partners and starting to build the infrastructure and assemble the resources necessary to further

Capitalizing on a rare opportunity to thoroughly analyze a tumor from a lung cancer patient who had developed resistance to targeted drug treatment, UC San Francisco scientists identified a biological escape hatch that explains the resistance, and developed a strategy in mice for shutting it down

In closing the 2015 UCSF Helen Diller Family Comprehensive Cancer Center Symposium, President Alan Ashworth, PhD, FRS, counted himself among those who might once have underappreciated the full potential of cancer immunotherapy. “But,” he declared, “it is clearly a field whose day has come.” He also

Christine Miaskowski, PhD, RN, the Sharon A. Lamb Endowed Chair in Symptom Management Research in the UCSF School of Nursing, is one of 19 nurse researchers being inducted into the International Nurse Researcher Hall of Fame by the Honor Society of Nursing, Sigma Theta Tau International (STTI)

A research team at UC San Francisco has won a five-year award of $14.1 million from the Patient-Centered Outcomes Research Institute (PCORI) to investigate whether a personalized approach to breast cancer screening is as safe and effective as annual mammograms. The project, called the WISDOM study

UC San Francisco chancellors emeriti J. Michael Bishop, MD, and Susan Desmond-Hellmann, MD, MPH, will appear next week in a Ken Burns-produced PBS documentary called “Cancer: The Emperor of All Maladies,” which is based on the Pulitzer Prize-winning book of the same name by Columbia University

A new study of acute lymphoblastic leukemia (ALL), a blood cancer that primarily affects young children, has revealed that the disease has two distinct subtypes, and provides preliminary evidence that about 13 percent of ALL cases may be successfully treated with targeted drugs that have proved